Catechol-bearing imidazolium and benzimidazolium chlorides as promising antimicrobial agents
dc.authorid | Özdemir, İsmail/0000-0001-6325-0216 | |
dc.authorid | Günal, Selami/0000-0002-4752-5176 | |
dc.authorid | Karataş, Mert Olgun/0000-0001-8500-2088 | |
dc.authorwosid | Özdemir, İsmail/ABI-5192-2020 | |
dc.authorwosid | Günal, Selami/AAA-7246-2021 | |
dc.authorwosid | Karataş, Mert Olgun/ABG-7848-2020 | |
dc.contributor.author | Karatas, Mert O. | |
dc.contributor.author | Gunal, Selami | |
dc.contributor.author | Mansur, Ahmet | |
dc.contributor.author | Alici, Bulent | |
dc.contributor.author | Ozdemir, Ismail | |
dc.date.accessioned | 2024-08-04T20:47:14Z | |
dc.date.available | 2024-08-04T20:47:14Z | |
dc.date.issued | 2020 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Catechol-containing imidazolium (four) and benzimidazolium chlorides (eight) were synthesized to evaluate their antimicrobial properties. All the compounds were fully characterized using H-1 and C-13 nuclear magnetic resonance, liquid chromatography-mass spectrometry, infrared spectroscopic methods, and elemental analyses. Antimicrobial activities of the compounds were tested against the bacteria Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Enterococcus faecalis, and the fungal strains Candida albicans and Candida glabrata, and promising results were achieved. The two most important benzyl-substituted benzimidazolium chlorides, 3l and 3k, showed comparable activity to vancomycin against MRSA. | en_US |
dc.identifier.doi | 10.1002/ardp.202000013 | |
dc.identifier.issn | 0365-6233 | |
dc.identifier.issn | 1521-4184 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 32301169 | en_US |
dc.identifier.scopus | 2-s2.0-85083511029 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1002/ardp.202000013 | |
dc.identifier.uri | https://hdl.handle.net/11616/99254 | |
dc.identifier.volume | 353 | en_US |
dc.identifier.wos | WOS:000526691400001 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley-V C H Verlag Gmbh | en_US |
dc.relation.ispartof | Archiv Der Pharmazie | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | antibacterial | en_US |
dc.subject | antifungal | en_US |
dc.subject | benzimidazolium | en_US |
dc.subject | catechol | en_US |
dc.subject | imidazolium | en_US |
dc.title | Catechol-bearing imidazolium and benzimidazolium chlorides as promising antimicrobial agents | en_US |
dc.type | Article | en_US |